Science
Mechanism of Action
It utilizes a multi-pathway anti-inflammatory approach by suppressing key pro-inflammatory cytokines including TNF-α and IL-6. Specifically, the constituent apigenin interferes with the COX-2 enzyme to block Prostaglandin E2 (PGE2) synthesis and inhibits histamine release, which directly neutralizes vascular redness and cutaneous swelling.
Research
Clinical Evidence
High confidence1%
Key findings
- 01 A long-term assessment of 3,851 subjects demonstrated an exceptionally low sensitization rate of 0.56%, confirming its status as a high-tolerance botanical.
- 02 Comparative trials indicate that a 1.0% concentration delivers anti-erythema effects comparable to a 0.25% low-potency hydrocortisone treatment without the steroid-associated side effects.
Transparency
Dusting Analysis
While often listed for marketing appeal at negligible levels (below 0.1%), clinical benchmarks suggest that a minimum of 1.0% is required to achieve therapeutic soothing comparable to pharmaceutical controls.
The Formula
Formulation
Stability
The extract remains thermally stable up to 80°C; however, to protect delicate volatile fractions such as bisabolol, it is ideally incorporated during the cooling phase (below 40°C).
Synergies
- Bisabolol
- Panthenol
- Allantoin
Conflicts
- Strong oxidizing agents
- High concentrations of cationic surfactants
Safety
Safety Profile
The CIR Expert Panel classifies this ingredient as safe. Although leave-on makeup typically caps usage at 0.5%, higher concentrations are well-tolerated in clinical settings.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A highly reliable, clinically-backed botanical for mitigating inflammation and reinforcing the skin barrier across all skin types.
Related
Similar Ingredients
Finding similar ingredients…